CS227791A3 - Mutant of clostridium histolyticum bacterium, process of its obtaining and its application for the production of collagenase without clostripain - Google Patents

Mutant of clostridium histolyticum bacterium, process of its obtaining and its application for the production of collagenase without clostripain Download PDF

Info

Publication number
CS227791A3
CS227791A3 CS912277A CS227791A CS227791A3 CS 227791 A3 CS227791 A3 CS 227791A3 CS 912277 A CS912277 A CS 912277A CS 227791 A CS227791 A CS 227791A CS 227791 A3 CS227791 A3 CS 227791A3
Authority
CS
Czechoslovakia
Prior art keywords
collagenase
clostripain
mutant
clostridium
clostridium histolyticum
Prior art date
Application number
CS912277A
Other languages
Czech (cs)
English (en)
Inventor
Milan Holjevac
C Ivan Udovici
Sonja Cizmek
Vlasta Sojak-Derkos
Stjepan Gamulin
C Vladimir Deli
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of CS227791A3 publication Critical patent/CS227791A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/145—Clostridium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/842—Clostridium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CS912277A 1990-07-23 1991-07-22 Mutant of clostridium histolyticum bacterium, process of its obtaining and its application for the production of collagenase without clostripain CS227791A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU144090 1990-07-23

Publications (1)

Publication Number Publication Date
CS227791A3 true CS227791A3 (en) 1992-03-18

Family

ID=25554178

Family Applications (1)

Application Number Title Priority Date Filing Date
CS912277A CS227791A3 (en) 1990-07-23 1991-07-22 Mutant of clostridium histolyticum bacterium, process of its obtaining and its application for the production of collagenase without clostripain

Country Status (10)

Country Link
US (1) US5252481A (de)
EP (1) EP0468411B1 (de)
JP (1) JPH05219942A (de)
AT (1) ATE130867T1 (de)
BG (1) BG94868A (de)
CA (1) CA2047306A1 (de)
CS (1) CS227791A3 (de)
DE (1) DE69114935T2 (de)
HU (1) HU912453D0 (de)
PL (1) PL291186A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332503A (en) * 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase
DE19521829A1 (de) * 1995-06-16 1996-12-19 Knoll Ag Neue Verwendung von Collagenase
KR100246820B1 (ko) * 1997-12-30 2000-03-15 정수련 신균주 트리고높시스 배리아빌리스에 의한 에리쓰리톨의 제조방법
US6001616A (en) * 1998-09-16 1999-12-14 Dong Cheon Consulting Co., Ltd. Process for preparing erythritol using novel cell of pichia
US7811560B2 (en) * 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
EP2130551B1 (de) * 2008-06-02 2012-06-06 Roche Diagnostics GmbH Verbesserte Reinigung von Kollagenasen aus flüssiger Clostridium histolyticum-Kultur
US10119131B2 (en) 2011-03-16 2018-11-06 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
EP4772625A2 (de) 2012-01-12 2026-07-08 Endo Biologics Limited Clostridium histolyticum enzym
WO2014144859A1 (en) 2013-03-15 2014-09-18 Biospecifics Technologies Corporation Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
DK3589204T3 (da) 2017-03-01 2025-06-30 Endo Operations Ltd Apparat og fremgangsmåde til vurdering og behandling af cellulitis
KR20250171475A (ko) 2017-03-28 2025-12-08 엔도 오퍼레이션즈 리미티드 개선된 콜라게나제 생성 방법
CZ308157B6 (cs) * 2017-09-13 2020-01-29 MB PHARMA s.r.o. Kmen bakterie Clostridium histolyticum, kolagenáza připravená s použitím tohoto kmene a její použití
AU2020366008B2 (en) 2019-10-15 2025-08-28 Biospecifics Technologies Corp. Treatment of uterine fibroids using purified collagenase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3201325A (en) * 1963-02-15 1965-08-17 Miles Lab Process for the recovery of collagenase
US3821364A (en) * 1966-07-08 1974-06-28 Advance Biofactures Corp Process of producing collagenase
US3705083A (en) * 1966-07-08 1972-12-05 Agricultural Biolog Corp Process for producing collagenase
US3677900A (en) * 1970-05-04 1972-07-18 Univ Lehigh Method of producing collagenase with a species of vibrio
FR2474052B1 (fr) * 1980-01-21 1984-04-20 Agronomique Inst Nat Rech Nouvelle collagenase, procede d'obtention et applications

Also Published As

Publication number Publication date
BG94868A (bg) 1993-12-24
EP0468411A2 (de) 1992-01-29
EP0468411A3 (en) 1992-09-23
EP0468411B1 (de) 1995-11-29
HU912453D0 (en) 1991-12-30
DE69114935D1 (de) 1996-01-11
CA2047306A1 (en) 1992-01-24
US5252481A (en) 1993-10-12
JPH05219942A (ja) 1993-08-31
ATE130867T1 (de) 1995-12-15
PL291186A1 (en) 1992-11-02
DE69114935T2 (de) 1996-05-30

Similar Documents

Publication Publication Date Title
Abdel-Fattah et al. Biodegradation of feather waste by keratinase produced from newly isolated Bacillus licheniformis ALW1
Nam et al. Native-feather degradation by Fervidobacterium islandicum AW-1, a newly isolated keratinase-producing thermophilic anaerobe
Tran et al. Isolation and characteristics of Bacillus subtilis CN2 and its collagenase production
US5252481A (en) Mutant of bacterium Clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase
Chandrasekaran et al. Exploring the in vitro thrombolytic activity of nattokinase from a new strain Pseudomonas aeruginosa CMSS
Batish et al. Studies on environmental and nutritional factors on production of antifungal substance byLactobacillus acidophilus R.
KR100413335B1 (ko) 항균 펩타이드 물질을 생산하는 유산균 락토코커스 락티스bh5(케이씨씨엠 10275)
Wang et al. Production of antifungal materials by bioconversion of shellfish chitin wastes fermented by Pseudomonas fluorescens K-188
AU615661B2 (en) Acid urease and production thereof
AU2018333356B2 (en) Bacterial strain Clostridium histolyticum and its use
US3677900A (en) Method of producing collagenase with a species of vibrio
RU2193063C2 (ru) Бактериолитический комплекс, способ его получения и штамм для осуществления способа
US3767533A (en) Process for producing uricase
Lehrer et al. Isolation and purification of endotoxin by hydrolytic enzymes
Cortezi et al. Characterization of a feather degrading by Bacillus amyloliquefaciens protease: a new strain
JP2898022B2 (ja) コラーゲン分解酵素の製造方法
US3345269A (en) Process for the production of proteolytic enzymes
Jois et al. STUDY ON PRODUCTION, PURIFICATION AND CHARACTERISATION OF L-ASPARAGINASE FROM ESCHERICHIA COLI AND PSEUDOMONAS AERUGINOSA.
Shwan et al. Production and purification of Nattokinase from Pseudomonas aeruginosa P49
US12628840B2 (en) Group of microorganisms composed by Lactobacillus sp strain K03D08, Bacillus sp strain K03B01 and Kazachstania sp strain K03K02G and its compositions; a process for obtaining casein-free dairy derivative containing short-chain fatty acids and hydroxylated short-chain fatty acids generated by the metabolism of the group of microorganisms
HRP920480A2 (en) Clostridium histolyticum bacterium mutant, its use for aring collagenase enzymes without clostripaine
JP2630391B2 (ja) ラクトバチルスに属する新菌種並びにその分離増殖方法
KR100376562B1 (ko) 비스루트균의 생산성을 향상시키는 방법
UA130663C2 (uk) Штам bacillus licheniformis - продуцент позаклітинної протеїнази з фібриногенолітичною активністю
SU1507788A1 (ru) Способ получени биомассы дрожжей CaNDIDo тRорIсаLIS К-1